A pilot study to test the effect of pulsatile insulin infusion on cardiovascular mechanisms that might contribute to attenuation of renal compromise in type 1 diabetes mellitus patients with proteinuria

被引:10
作者
Weinrauch, Larry A.
Burger, Andrew J.
Aepfelbacher, Franz
Lee, Annette T.
Gleason, Ray E.
D'Elia, John A.
机构
[1] Joslin Diabet Ctr, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Mt Auburn Hosp, Cambridge, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] N Shore Univ Hosp, Manhasset, NY USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2007年 / 56卷 / 11期
关键词
IMPROVED GLYCEMIC CONTROL; GROWTH-FACTOR; INTERMITTENT; DYSFUNCTION; METABOLISM; GLYCATION; OXIDATION; THERAPY; GLUCOSE;
D O I
10.1016/j.metabol.2007.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that correction of insulin deficiency by pulsatile intravenous insulin infusion in type I diabetes mellims patients with nephropathy preserves renal function by mechanisms involving cardiac autonomic function, cardiac mass, or efficiency, or by hemostatic mechanisms. The control group (8 patients) received subcutaneous insulin (34 injections per day). The intravenous infusion group (10 patients) received three I -hour courses of pulsed intravenous insulin infusion on a single day per week in addition to subcutaneous insulin. Laboratory measurements included 2-dimensional Doppler echocardiography, 24-hour ambulatory monitoring with heart rate variation analysis, platelet aggregation and adhesion, plasma fibrinogen, factor VII, von Willebrand factor, fibrinolytic activity, plasminogen activator inhibitor, and viscosity measured at baseline and 12 months. Blood pressure control was maintained preferentially with angiotensin-converting enzyme inhibitors. Ratio of carbon dioxide production to oxygen utilization was measured with each infusion and showed rapid increase from 0.8 to 0.9 (P =.005) at weekly treatments through 12 months. We observed an annualized decrease in creatinine clearance of 9.6 mL/min for controls vs 3.0 mL/min for infusion patients. Annualized fall in blood hemoglobin was 1.9 vs 0.8 g/dL, respectively (P =.013). There were no differences between the control and infusion group with respect to glycohemoglobin, advanced glycated end products, cholesterol, or triglycerides. No differences between the study groups for hernodynamic or hemostatic factors were evident. Blood pressures were not significantly different at baseline or 12 months. We conclude that although preservation of renal function with attenuation of loss of blood hemoglobin during 12 months of intravenous insulin infusion was associated with improvement in the efficiency of fuel oxidation as measured by respiratory quotient, this occurred without differences in metabolic/hemostatic factors, cardiac autonomic function, cardiac wall, or chamber size. Our hypothesis that preservation of renal function in type I diabetes mellitus patients with proteinuria by weekly pulsed insulin infusion involves mechanisms from the autonomic nervous system, cardiac size, and function, or elements of hernostasis was not confirmed. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1453 / 1457
页数:5
相关论文
共 22 条
[1]   Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus [J].
Aepfelbacher, FC ;
Yeon, SB ;
Weinrauch, LA ;
D'Elia, J ;
Burger, AJ .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 94 (01) :47-51
[2]   CHRONIC INTERMITTENT INTRAVENOUS INSULIN THERAPY CORRECTS ORTHOSTATIC HYPOTENSION OF DIABETES [J].
AOKI, TT ;
GRECU, EO ;
ARCANGELI, MA .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06) :683-684
[3]   EVIDENCE FOR RESTORATION OF HEPATIC GLUCOSE PROCESSING IN TYPE-I DIABETES-MELLITUS [J].
AOKI, TT ;
VLACHOKOSTA, FV ;
FOSS, MC ;
MEISTAS, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (04) :837-839
[4]  
AOKI TT, 1993, LANCET, V342, P525
[5]   Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin [J].
Avignon, A ;
Lapinski, H ;
Rabasa-Lhoret, R ;
Caubel, C ;
Boniface, H ;
Monnier, L .
DIABETES OBESITY & METABOLISM, 2000, 2 (04) :229-235
[6]   Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy [J].
Burger, AJ ;
Weinrauch, LA ;
D'Elia, JA ;
Aronson, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06) :687-691
[7]   Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications [J].
D'Elia, JA ;
Weinrauch, LA ;
Gleason, RE ;
Lipinska, I ;
Keough, J ;
Pendse, S ;
Roshan, B ;
Lee, AT ;
Tofler, GH .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) :98-101
[8]   Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy [J].
Dailey, GE ;
Boden, GH ;
Creech, RH ;
Johnson, DG ;
Gleason, RE ;
Kennedy, FP ;
Weinrauch, LA ;
Weir, M ;
D'Elia, JA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11) :1491-1495
[9]   INCREASED RENAL METABOLISM IN DIABETES MECHANISM AND FUNCTIONAL IMPLICATIONS [J].
KORNER, A ;
EKLOF, AC ;
CELSI, G ;
APERIA, A .
DIABETES, 1994, 43 (05) :629-633
[10]   DIFFERENT EFFECTS OF INTERMITTENT AND CONTINUOUS GROWTH-HORMONE (GH) ADMINISTRATION ON SERUM SOMATOMEDIN-C INSULIN-LIKE GROWTH FACTOR-I AND LIVER GH RECEPTORS IN HYPOPHYSECTOMIZED RATS [J].
MAITER, D ;
UNDERWOOD, LE ;
MAES, M ;
DAVENPORT, ML ;
KETELSLEGERS, JM .
ENDOCRINOLOGY, 1988, 123 (02) :1053-1059